Trial intelligence / Profile preview

Sevoflurane Induction for Intubation in Pediatric Congenital Heart Disease

ChiCTR-IPR-16007818Phase 4Recruiting

Sponsor
Yantai Mountain Hospital
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of sevoflurane in Cardiovascular Malformation (CVM) (2 arms), sponsored by Yantai Mountain Hospital. Primary endpoint: Endothelin. Started Jan 2016; status: recruiting.

02

Drugs

sevoflurane
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on ChiCTR-IPR-16007818.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16007818.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call